Concepedia

William Irvin

WI

Statistics

Publications

26

Citations

1.4K

H-Index

19

Active since

1998

Affiliations

University of North Carolina at Chapel Hill(Current)

Virginia Cancer Institute

UNC Lineberger Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Brigham and Women's Hospital

William Irvin is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

1998–2025

26

Publications

26

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

William Irvin, Christine M. Walko, Karen E. Weck et al. · Journal of Clinical Oncology · 2011 · 179 citations

, , +17

TBCRC 001: EGFR inhibition with cetuximab added to carboplatin in metastatic triple-negative (basal-like) breast cancer

LA Carey, Hope S. Rugo, P. Kelly Marcom et al. · Journal of Clinical Oncology · 2008 · 163 citations

, , +17

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

Deborah Schrag, Hajime Uno, Rachel Rosovsky et al. · JAMA · 2023 · 141 citations · Full text

, , +17

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Costanza Paoletti, Yufeng Li, Maria C. Muñiz et al. · Clinical Cancer Research · 2015 · 86 citations · Full text

, , +17

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

Eleftherios P. Mamounas, Hanna Bandos, Julia White et al. · New England Journal of Medicine · 2025 · 86 citations · Full text

, , +16

1–5 of 26